Sandra L Hatten - Net Worth and Insider Trading

Sandra L Hatten Net Worth

The estimated net worth of Sandra L Hatten is at least $1 Million dollars as of 2024-05-01. Sandra L Hatten is the See Remarks of Avadel Pharmaceuticals PLC and owns about 59,165 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $1 Million. Sandra L Hatten is also the Sr. VP, Quality of Mallinckrodt PLC and owns about 6,642 shares of Mallinckrodt PLC (MNKKQ) stock worth over $133. Details can be seen in Sandra L Hatten's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandra L Hatten has not made any transactions after 2019-12-12 and currently still holds the listed stock(s).

Transaction Summary of Sandra L Hatten

To

Sandra L Hatten Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sandra L Hatten owns 3 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Mallinckrodt PLC (MNKKQ) , and Mallinckrodt PLC (MCKPF) .

Click here to see the complete history of Sandra L Hatten’s form 4 insider trades.

Insider Ownership Summary of Sandra L Hatten

Ticker Comapny Transaction Date Type of Owner
AVDL Avadel Pharmaceuticals PLC 2019-12-12 See Remarks
MNKKQ Mallinckrodt PLC 2015-05-11 Sr. Vice President Quality
MCKPF Mallinckrodt PLC 2014-02-20 Sr. Vice President Quality

Sandra L Hatten Latest Holdings Summary

Sandra L Hatten currently owns a total of 2 stocks. Among these stocks, Sandra L Hatten owns 59,165 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 12, 2019, with a value of $1 Million and a weighting of 99.99%. Sandra L Hatten also owns 6,642 shares of Mallinckrodt PLC (MNKKQ) as of May 11, 2015, with a value of $133 and a weighting of 0.01%.

Latest Holdings of Sandra L Hatten

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVDL Avadel Pharmaceuticals PLC 2019-12-12 59,165 18.63 1,102,244
MNKKQ Mallinckrodt PLC 2015-05-11 6,642 0.02 133

Holding Weightings of Sandra L Hatten


Sandra L Hatten Form 4 Trading Tracker

According to the SEC Form 4 filings, Sandra L Hatten has made a total of 1 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 3,072 shares on December 12, 2019, which brought Sandra L Hatten around $22,211.

According to the SEC Form 4 filings, Sandra L Hatten has made a total of 0 transactions in Mallinckrodt PLC (MNKKQ) over the past 5 years. The most-recent trade in Mallinckrodt PLC is the sale of 2,024 shares on May 11, 2015, which brought Sandra L Hatten around $247,515.

Insider Trading History of Sandra L Hatten

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sandra L Hatten Trading Performance

GuruFocus tracks the stock performance after each of Sandra L Hatten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandra L Hatten is -8.16%. GuruFocus also compares Sandra L Hatten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandra L Hatten within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sandra L Hatten's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sandra L Hatten

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.75
Relative Return to S&P 500(%) 9.57

Sandra L Hatten Ownership Network

Ownership Network List of Sandra L Hatten

No Data

Ownership Network Relation of Sandra L Hatten


Sandra L Hatten Owned Company Details

What does Avadel Pharmaceuticals PLC do?

Who are the key executives at Avadel Pharmaceuticals PLC?

Sandra L Hatten is the See Remarks of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .

Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary

Over the past 18 months, Sandra L Hatten made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 33,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avadel Pharmaceuticals PLC Insider Transactions

No Available Data

Sandra L Hatten Mailing Address

Above is the net worth, insider trading, and ownership report for Sandra L Hatten. You might contact Sandra L Hatten via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.

Discussions on Sandra L Hatten

No discussions yet.